Illumina is acquiring Grail for $8 billion. Market watchers hate this deal… but it will fortify Illumina’s position as one of the world’s most important biotech companies for decades to come.
So where have all the good investments gone? Where is the chance to invest in the next Amazon? They’re still out there…
A team of researchers from the U.K. made an incredible discovery… and it’s raising the question: “Could there be life on Venus?”
The next two years will be brutal for companies that don’t adapt quickly to this new environment…
The USPTO granted Broad Institute’s motion for priority benefit to its early CRISPR patents. This is great news for the industry and CRISPR companies…
I’m very bullish on Tesla, and I believe it has a bright future ahead. But investing at these elevated “expensive” levels isn’t investing… It’s just speculation
This exciting biotechnology firm with a method to detect early stage cancer is about to IPO. We’ll keep a close eye on this pick in the coming months…